N-[2-(4-Methylpiperazin-1-yl)phenyl]-3-(trifluoromethyl)benzamide

Catalog No.: 
ACVMDT750
CAS No.: 
400076-90-6
Molecular Formula: 
C19H20F3N3O
Molecular Weight: 
363.38
N-[2-(4-Methylpiperazin-1-yl)phenyl]-3-(trifluoromethyl)benzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$104.00InquiryInquiry
1g90%$322.00InquiryInquiry
5g90%$1578.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-[2-(4-Methylpiperazin-1-yl)phenyl]-3-(trifluoromethyl)benzamide
IUPAC NameN-(2-(4-methylpiperazin-1-yl)phenyl)-3-(trifluoromethyl)benzamide
Molecular FormulaC19H20F3N3O
Molecular Weight363.38
SMILESO=C(NC1=CC=CC=C1N2CCN(C)CC2)C3=CC=CC(C(F)(F)F)=C3
InChI KeyOUXUXCDAFCGFNP-UHFFFAOYSA-N
SynonymN-[2-(4-methylpiperazin-1-yl)phenyl]-3-(trifluoromethyl)benzamide;Benzamide, N-[2-(4-methyl-1-piperazinyl)phenyl]-3-(trifluoromethyl)-
CAS No.400076-90-6

Synthetic Route by SureRoute

1. ACVMDT750 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXCZW829 route compound structure diagram
    ACXCZW829180605-36-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVMDT750 route product structure diagram
    ACVMDT750400076-90-6
Inquiry

2. ACVMDT750 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXCZW829 route compound structure diagram
    ACXCZW829180605-36-1In Stock
  2. Plus
  3. ACHTIW589 route compound structure diagram
    ACHTIW589454-92-2In Stock
  4. Then
  5. ACVMDT750 route product structure diagram
    ACVMDT750400076-90-6
Inquiry

3. ACVMDT750 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVMDT750 route product structure diagram
    ACVMDT750400076-90-6
Inquiry

Comments (0)